Table 3 The risk factors for higher prevalence of HK (> 5.5 mmol/L).

From: Prevalence, practice pattern, and mortality of hyperkalemia in Chinese patients undergoing hemodialysis in the visualize HD study

Variables (%)

Univariate OR (95% CI)

P

Multivariate OR (95% CI)

P

Age (≥ 65 years)

0.975 (0.953, 0.997)

0.024

  

Sex (male)

1.030 (1.001, 1.059)

0.043

1.042 (1.005,1.081)

0.025

Dialysis frequency ≥ 3 (times/ week)

0.994 (0.987,1.002)

0.150

  

Dialysis vintage ≥ 5 (years)

1.007 (0.991,1.023)

0.440

  

Hemoglobin ≥ 90 (g/L)

1.011 (0.990, 1.034)

0.303

  

Albuminbu ≥ 40 (g/L)

1.006 (0.993,1.019)

0.361

  

Phosphorus (mmol/L)

1.040 (1.014, 1.067)

0.003

1.041 (1.010,1.072)

0.008

RAASi usage

1.001 (0.993, 1.009)

0.585

  

Diuretics usage

1.007 (0.978, 1.037)

0.632

  

Potassium binders

1.028 (0.998, 1.059)

0.070

  

patients’ treatment time > 210 min

0.982 (0.942,1.024)

0.393

  
  1. CI confidence interval, HK hyperkalemia, RAASi included angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, mineralocorticoid receptor antagonist, and angiotensin receptor/neprilysin inhibitor (ARNI), OR odd’s ratio.
Back to article page